Fulcrum Therapeutics, Inc. (FULC)
3.505
-0.02
(-0.43%)
USD |
NASDAQ |
Jun 10, 16:00
3.505
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Market Cap : 233.46M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 234.46M |
| June 08, 2026 | 229.13M |
| June 05, 2026 | 245.78M |
| June 04, 2026 | 224.47M |
| June 03, 2026 | 214.48M |
| June 02, 2026 | 209.15M |
| June 01, 2026 | 427.62M |
| May 29, 2026 | 460.93M |
| May 28, 2026 | 454.27M |
| May 27, 2026 | 451.77M |
| May 26, 2026 | 450.44M |
| May 22, 2026 | 437.78M |
| May 21, 2026 | 439.11M |
| May 20, 2026 | 423.12M |
| May 19, 2026 | 393.80M |
| May 18, 2026 | 405.80M |
| May 15, 2026 | 445.78M |
| May 14, 2026 | 473.76M |
| May 13, 2026 | 483.09M |
| May 12, 2026 | 463.77M |
| May 11, 2026 | 466.43M |
| May 08, 2026 | 467.10M |
| May 07, 2026 | 458.44M |
| May 06, 2026 | 473.76M |
| May 05, 2026 | 467.77M |
| Date | Value |
|---|---|
| May 04, 2026 | 467.77M |
| May 01, 2026 | 490.42M |
| April 30, 2026 | 475.10M |
| April 29, 2026 | 476.43M |
| April 28, 2026 | 495.75M |
| April 27, 2026 | 514.41M |
| April 24, 2026 | 522.41M |
| April 23, 2026 | 538.40M |
| April 22, 2026 | 516.41M |
| April 21, 2026 | 501.75M |
| April 20, 2026 | 528.81M |
| April 17, 2026 | 552.12M |
| April 16, 2026 | 532.14M |
| April 15, 2026 | 549.45M |
| April 14, 2026 | 526.14M |
| April 13, 2026 | 514.82M |
| April 10, 2026 | 502.83M |
| April 09, 2026 | 526.81M |
| April 08, 2026 | 526.14M |
| April 07, 2026 | 521.48M |
| April 06, 2026 | 521.48M |
| April 02, 2026 | 535.47M |
| April 01, 2026 | 498.17M |
| March 31, 2026 | 510.82M |
| March 30, 2026 | 438.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.92M |
| CNBX Pharmaceuticals, Inc. | 0.1914M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 449.89M |
| Definium Therapeutics, Inc. | 2.418B |
Market Cap Related Metrics
| PEG Ratio | -0.0019 |
| Price to Book Value | 0.7004 |
| Price | 3.505 |
| Earnings Yield | -32.71% |
| PEGY Ratio | -0.0019 |